Aspire Biopharma Holdings, Inc.
ASBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,850 | -$1,981 | -$15,941 | -$8,931 |
| Dep. & Amort. | $2,021 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $14,131 | $0 |
| Change in WC | $1,637 | -$260 | -$326 | $1,218 |
| Other Non-Cash | -$2,912 | $1,101 | $385 | $8,193 |
| Operating Cash Flow | -$1,104 | -$1,140 | -$1,752 | $480 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,846 | $0 | $2,829 | -$1,115 |
| Stock Issued | $0 | $0 | $266 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$258 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $881 |
| Financing Cash Flow | $2,846 | $0 | $3,094 | -$492 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,742 | -$1,140 | $1,343 | -$13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $206 | $1,347 | $4 | $17 |
| End Cash | $1,948 | $206 | $1,347 | $4 |
| Free Cash Flow | -$1,104 | -$1,140 | -$1,752 | $480 |